294 related articles for article (PubMed ID: 16172287)
1. Losartan metabolite EXP3179 activates Akt and endothelial nitric oxide synthase via vascular endothelial growth factor receptor-2 in endothelial cells: angiotensin II type 1 receptor-independent effects of EXP3179.
Watanabe T; Suzuki J; Yamawaki H; Sharma VK; Sheu SS; Berk BC
Circulation; 2005 Sep; 112(12):1798-805. PubMed ID: 16172287
[TBL] [Abstract][Full Text] [Related]
2. Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive properties.
Sauge E; Pechkovsky D; Atmuri NDP; Tehrani AY; White Z; Dong Y; Cait J; Hughes M; Tam A; Donen G; Yuen C; Walker MJA; McNagny KM; Sin DD; Ciufolini MA; Bernatchez P
Vascul Pharmacol; 2022 Dec; 147():107112. PubMed ID: 36179789
[TBL] [Abstract][Full Text] [Related]
3. Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling.
Su KH; Tsai JY; Kou YR; Chiang AN; Hsiao SH; Wu YL; Hou HH; Pan CC; Shyue SK; Lee TS
Cardiovasc Res; 2009 Jun; 82(3):468-75. PubMed ID: 19307231
[TBL] [Abstract][Full Text] [Related]
4. Losartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2/Src/Akt pathway in type 2 diabetic Goto-Kakizaki rats.
Nemoto S; Kobayashi T; Taguchi K; Matsumoto T; Kamata K
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2383-94. PubMed ID: 21926342
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
Zhao Y; Chen X; Cai L; Yang Y; Sui G; Fu S
J Cell Physiol; 2010 Oct; 225(1):168-73. PubMed ID: 20458733
[TBL] [Abstract][Full Text] [Related]
6. Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites.
Schupp M; Lee LD; Frost N; Umbreen S; Schmidt B; Unger T; Kintscher U
Hypertension; 2006 Mar; 47(3):586-9. PubMed ID: 16365190
[TBL] [Abstract][Full Text] [Related]
7. Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension.
Fortuño A; Bidegain J; Robador PA; Hermida J; López-Sagaseta J; Beloqui O; Díez J; Zalba G
Hypertension; 2009 Oct; 54(4):744-50. PubMed ID: 19687351
[TBL] [Abstract][Full Text] [Related]
8. Losartan, an angiotensin II type 1 receptor blocker, ameliorates cerebral ischemia-reperfusion injury via PI3K/Akt-mediated eNOS phosphorylation.
Liu H; Liu X; Wei X; Chen L; Xiang Y; Yi F; Zhang X
Brain Res Bull; 2012 Oct; 89(1-2):65-70. PubMed ID: 22766267
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with losartan results in sufficient serum levels of the metabolite EXP3179 for PPARgamma activation.
Kappert K; Tsuprykov O; Kaufmann J; Fritzsche J; Ott I; Goebel M; Bähr IN; Hässle PL; Gust R; Fleck E; Unger T; Stawowy P; Kintscher U
Hypertension; 2009 Oct; 54(4):738-43. PubMed ID: 19687349
[TBL] [Abstract][Full Text] [Related]
10. Flow shear stress stimulates Gab1 tyrosine phosphorylation to mediate protein kinase B and endothelial nitric-oxide synthase activation in endothelial cells.
Jin ZG; Wong C; Wu J; Berk BC
J Biol Chem; 2005 Apr; 280(13):12305-9. PubMed ID: 15665327
[TBL] [Abstract][Full Text] [Related]
11. Propionyl-L-carnitine induces eNOS activation and nitric oxide synthesis in endothelial cells via PI3 and Akt kinases.
Ning WH; Zhao K
Vascul Pharmacol; 2013; 59(3-4):76-82. PubMed ID: 23850990
[TBL] [Abstract][Full Text] [Related]
12. Fast relaxation and desensitization of angiotensin II contraction in the pulmonary artery via AT1R and Akt-mediated phosphorylation of muscular eNOS.
Kim HJ; Jang JH; Zhang YH; Yoo HY; Kim SJ
Pflugers Arch; 2019 Oct; 471(10):1317-1330. PubMed ID: 31468138
[TBL] [Abstract][Full Text] [Related]
13. Low shear stress induces endothelial reactive oxygen species via the AT1R/eNOS/NO pathway.
Chao Y; Ye P; Zhu L; Kong X; Qu X; Zhang J; Luo J; Yang H; Chen S
J Cell Physiol; 2018 Feb; 233(2):1384-1395. PubMed ID: 28518223
[TBL] [Abstract][Full Text] [Related]
14. AT1 receptor blocker potentiates shear-stress induced nitric oxide production via modulation of eNOS phosphorylation of residues Thr(495) and Ser(1177.).
Barauna VG; Mantuan PR; Magalhães FC; Campos LC; Krieger JE
Biochem Biophys Res Commun; 2013 Nov; 441(4):713-9. PubMed ID: 24211212
[TBL] [Abstract][Full Text] [Related]
15. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
Gélinas DS; Bernatchez PN; Rollin S; Bazan NG; Sirois MG
Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy-enhanced endothelial nitric oxide synthase (eNOS) activation in uterine artery endothelial cells shows altered sensitivity to Ca2+, U0126, and wortmannin but not LY294002--evidence that pregnancy adaptation of eNOS activation occurs at multiple levels of cell signaling.
Sullivan JA; Grummer MA; Yi FX; Bird IM
Endocrinology; 2006 May; 147(5):2442-57. PubMed ID: 16455784
[TBL] [Abstract][Full Text] [Related]
17. VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells.
Feliers D; Chen X; Akis N; Choudhury GG; Madaio M; Kasinath BS
Kidney Int; 2005 Oct; 68(4):1648-59. PubMed ID: 16164642
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs.
Presta I; Tassone EJ; Andreozzi F; Perticone M; Sciacqua A; Laino I; Musca D; Martino F; Sesti G; Perticone F
Atherosclerosis; 2011 Dec; 219(2):463-7. PubMed ID: 21937042
[TBL] [Abstract][Full Text] [Related]
19. Adropin is a novel regulator of endothelial function.
Lovren F; Pan Y; Quan A; Singh KK; Shukla PC; Gupta M; Al-Omran M; Teoh H; Verma S
Circulation; 2010 Sep; 122(11 Suppl):S185-92. PubMed ID: 20837912
[TBL] [Abstract][Full Text] [Related]
20. Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase.
Viswambharan H; Ming XF; Zhu S; Hubsch A; Lerch P; Vergères G; Rusconi S; Yang Z
Circ Res; 2004 Apr; 94(7):918-25. PubMed ID: 14988229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
